BioNTech SE(BNTX) - 2025 Q2 - Earnings Call Presentation

2nd Quarter 2025 Financial Results & Corporate Update August 4th, 2025 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, but not limited to, statements concerning: BioNTech's expected revenues and net profit/(loss) related to sales of BioNTech's COVID-19 vaccine, referred to as COMIRNATY where approved for use under full or conditional marketing authorization, in territories controlled by BioNTech's collab ...